BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
Symetis is defunct.

Fate: Acquired by Boston Scientific, May 2017, $435M


------------------
If you believe any of this information is incorrect, please let us know.